Biogen Inc (BIIB)
151.31
+1.41
(+0.94%)
USD |
NASDAQ |
Dec 27, 16:00
151.40
+0.09
(+0.06%)
After-Hours: 20:00
Biogen SG&A Expense (Quarterly): 588.40M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly and Co | 2.100B |
| Pfizer Inc | 3.244B |
| Amgen Inc | 1.625B |
| Merck & Co Inc | 2.731B |
| Moderna Inc | 281.00M |